Genetic Markers Used for Risk Stratification in Multiple Myeloma

por Segges, Priscilla, Braggio, Esteban
Publicado 2011

Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature

por Ayres-Silva, Jackline P., Bonamino, Martin H., Gouveia, Maria E., Monte-Mor, Barbara C. R., Coutinho, Diego F., Daumas, Adelmo H., Solza, Cristiana, Braggio, Esteban, Zalcberg, Ilana Renault
Publicado 2018

Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

por Braggio, Esteban, Dogan, Ahmet, Keats, Jonathan J, Chng, Wee J, Huang, Gaofeng, Matthews, Julie M, Maurer, Matthew J, Law, Mark E, Bosler, David S, Barrett, Michael, Lossos, Izidore S, Witzig, Thomas, Fonseca, Rafael
Publicado 2012

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

por Zhu, Yuan Xiao, Shi, Chang-Xin, Bruins, Laura A., Wang, Xuewei, Riggs, Daniel L., Porter, Brooke, Ahmann, Jonathan M., de Campos, Cecilia Bonolo, Braggio, Esteban, Bergsagel, P. Leif, Stewart, A. Keith
Publicado 2019

Transcriptional profiles define drug refractory disease in myeloma

por Zhu, Yuan Xiao, Bruins, Laura A., Chen, Xianfeng, Shi, Chang‐Xin, Bonolo De Campos, Cecilia, Meurice, Nathalie, Wang, Xuewei, Ahmann, Greg J., Ramsower, Colleen A., Braggio, Esteban, Rimsza, Lisa M., Stewart, A. Keith
Publicado 2022

Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma

por Liu, Yang, Quang, Phong, Braggio, Esteban, Ngo, Hai, Badalian-Very, Gayane, Flores, Ludmila, Zhang, Yong, Sacco, Antonio, Maiso, Patricia, Azab, Abdel Kareem, Azab, Feda, Carrasco, Ruben, Rollins, Barrett J., Roccaro, Aldo M., Ghobrial, Irene M.
Publicado 2013

An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma

por Watkins, A. James, Hamoudi, Rifat A., Zeng, Naiyan, Yan, Qingguo, Huang, Yuanxue, Liu, Hongxiang, Zhang, Jianzhong, Braggio, Esteban, Fonseca, Rafael, de Leval, Laurence, Isaacson, Peter G., Wotherspoon, Andrew, McPhail, Ellen D., Dogan, Ahmet, Du, Ming-Qing
Publicado 2012

Loss of TNFAIP3 enhances MYD88(L265P)-driven signaling in non-Hodgkin lymphoma

por Wenzl, Kerstin, Manske, Michelle K., Sarangi, Vivekananda, Asmann, Yan W., Greipp, Patricia T., Schoon, Hanna R., Braggio, Esteban, Maurer, Matthew J., Feldman, Andrew L., Witzig, Thomas E., Slager, Susan L., Ansell, Stephen M., Cerhan, James R., Novak, Anne J.
Publicado 2018

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells

por Wang, Zhiquan, Yan, Huihuang, Boysen, Justin C., Secreto, Charla R., Tschumper, Renee C., Ali, Dania, Guo, Qianqian, Zhong, Jian, Zhou, Jiaqi, Gan, Haiyun, Yu, Chuanhe, Jelinek, Diane F., Slager, Susan L., Parikh, Sameer A., Braggio, Esteban, Kay, Neil E.
Publicado 2022

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis

por Parikh, Sameer A., Achenbach, Sara J., Rabe, Kari G., Norman, Aaron D., Boddicker, Nicholas J., Olson, Janet E., Call, Timothy G., Cerhan, James R., Vachon, Celine M., Kay, Neil E., Braggio, Esteban, Hanson, Curtis A., Slager, Susan L., Shanafelt, Tait D.
Publicado 2022

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

por Vendramini, Elena, Bomben, Riccardo, Pozzo, Federico, Benedetti, Dania, Bittolo, Tamara, Rossi, Francesca Maria, Dal Bo, Michele, Rabe, Kari G., Pozzato, Gabriele, Zaja, Francesco, Chiarenza, Annalisa, Di Raimondo, Francesco, Braggio, Esteban, Parikh, Sameer A., Kay, Neil E., Shanafelt, Tait D., Del Poeta, Giovanni, Gattei, Valter, Zucchetto, Antonella
Publicado 2019

Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis

por Boddicker, Nicholas J., Achenbach, Sara J., Parikh, Sameer A., Kleinstern, Geffen, Braggio, Esteban, Norman, Aaron D., Rabe, Kari G., Vachon, Celine M., Lesnick, Connie E., Call, Timothy G., Olson, Janet E., Cerhan, James R., Kay, Neil E., Hanson, Curtis A., Shanafelt, Tait D., Slager, Susan L.
Publicado 2022

Progression and survival of MBL: a screening study of 10 139 individuals

por Slager, Susan L., Parikh, Sameer A., Achenbach, Sara J., Norman, Aaron D., Rabe, Kari G., Boddicker, Nicholas J., Olson, Janet E., Kleinstern, Geffen, Lesnick, Connie E., Call, Timothy G., Cerhan, James R., Vachon, Celine M., Kay, Neil E., Braggio, Esteban, Hanson, Curtis A., Shanafelt, Tait D.
Publicado 2022

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

por Parikh, Sameer A., Rabe, Kari G., Kay, Neil E., Call, Timothy G., Ding, Wei, Leis, Jose F., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Koehler, Amber B., Schwager, Susan M., Lesnick, Connie E., Kleinstern, Geffen, Van Dyke, Daniel, Hanson, Curtis A., Braggio, Esteban, Slager, Susan L., Shanafelt, Tait D.
Publicado 2021

Relationship among three common hematological premalignant conditions

por Boddicker, Nicholas J., Parikh, Sameer A., Norman, Aaron D., Rabe, Kari G., Griffin, Rosalie, Call, Timothy G., Robinson, Dennis P., Olson, Janet E., Dispenzieri, Angela, Rajkumar, Vincent, Kumar, Shaji, Kay, Neil E., Hanson, Curtis A., Cerhan, James R., Murray, David, Braggio, Esteban, Shanafelt, Tait D., Vachon, Celine M., Slager, Susan L.
Publicado 2023

Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma

por Smadbeck, James, Peterson, Jess F., Pearce, Kathryn E., Pitel, Beth A., Figueroa, Andrea Lebron, Timm, Michael, Jevremovic, Dragan, Shi, Min, Stewart, A. Keith, Braggio, Esteban, Riggs, Daniel L., Bergsagel, P. Leif, Vasmatzis, George, Kearney, Hutton M., Hoppman, Nicole L., Ketterling, Rhett P., Kumar, Shaji, Rajkumar, S. Vincent, Greipp, Patricia T., Baughn, Linda B.
Publicado 2019

Identification of PIKfyve kinase as a target in multiple myeloma

por de Campos, Cecilia Bonolo, Zhu, Yuan Xiao, Sepetov, Nikolai, Romanov, Sergei, Bruins, Laura Ann, Shi, Chang-Xin, Stein, Caleb K., Petit, Joachim L., Polito, Alysia N., Sharik, Meaghen E., Meermeier, Erin W., Ahmann, Gregory J., Armenta, Ilsel D. Lopez, Kruse, Jonas, Bergsagel, P. Leif, Chesi, Marta, Meurice, Nathalie, Braggio, Esteban, Stewart, A. Keith
Publicado 2020

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib

por Hampel, Paul J., Rabe, Kari G., Call, Timothy G., Ding, Wei, Leis, Jose F., Chanan-Khan, Asher A., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber B., Parrondo, Ricardo, Schwager, Susan M., Sher, Taimur, Hanson, Curtis A., Shi, Min, Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.
Publicado 2022

Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL

por Griffin, Rosalie, Wiedmeier-Nutor, Julia E., Parikh, Sameer A., McCabe, Chantal E., O'Brien, Daniel R., Boddicker, Nicholas J., Kleinstern, Geffen, Rabe, Kari G., Bruins, Laura, Brown, Sochilt, Bonolo de Campos, Cecilia, Ding, Wei, Leis, Jose F., Hampel, Paul J., Call, Timothy G., Van Dyke, Daniel L., Kay, Neil E., Cerhan, James R., Yan, Huihuang, Slager, Susan L., Braggio, Esteban
Publicado 2023

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

por Shanafelt, Tait D., Wang, Xin Victoria, Hanson, Curtis A., Paietta, Elisabeth M., O’Brien, Susan, Barrientos, Jacqueline, Jelinek, Diane F., Braggio, Esteban, Leis, Jose F., Zhang, Cong Christine, Coutre, Steven E., Barr, Paul M., Cashen, Amanda F., Mato, Anthony R., Singh, Avina K., Mullane, Michael P., Little, Richard F., Erba, Harry, Stone, Richard M., Litzow, Mark, Tallman, Martin, Kay, Neil E.
Publicado 2022